Influenzavirus B Infection Drug Market Report

Global and Region Influenzavirus B Infection Drug Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 03, 2022
  • PAGES：231
  • REPORT CODE：GMM1015975
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Influenzavirus B Infection Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Influenzavirus B Infection Drugmarket, defines the market attractiveness level of Influenzavirus B Infection Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Influenzavirus B Infection Drug industry, describes the types of Influenzavirus B Infection Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Influenzavirus B Infection Drug market and the development prospects and opportunities of Influenzavirus B Infection Drug industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Influenzavirus B Infection Drug market in Chapter 13.

    By Player:

    • Aphios Corp

    • Adimmune Corp

    • Cadila Healthcare Ltd

    • Green Cross Corp

    • Shionogi & Co Ltd

    • Inovio Pharmaceuticals Inc

    • GlaxoSmithKline Plc

    • Mucosis BV

    • SK Chemicals Co Ltd

    • Sanofi Pasteur SA

    • ContraFect Corp

    • TSRL Inc

    • Medicago Inc

    • Amarillo Biosciences Inc

    • Vaxart Inc

    • Daiichi Sankyo Company Ltd

    • Kineta Inc

    • Fujifilm Holdings Corporation

    • Novavax Inc

    • BioCryst Pharmaceuticals Inc

    • Romark Laboratories LC

    • Romark Laboratories LC Pasteur SA

    • Altravax Inc

    • MedImmune LLC

    • Vectura Group Plc

    • AbbVie Inc

    • Park Active Molecules

    By Type:

    • APP-309

    • CF-403

    • GC-3106A

    • KIN-1400

    • Others

    By End-User:

    • Clinic

    • Hospital

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Influenzavirus B Infection Drug Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Influenzavirus B Infection Drug Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Influenzavirus B Infection Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Influenzavirus B Infection Drug Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Influenzavirus B Infection Drug Market Analysis and Outlook to 2022

    • 7.1 Global Influenzavirus B Infection Drug Consumption (2017-2022)

    • 7.2 United States Influenzavirus B Infection Drug Consumption (2017-2022)

    • 7.3 Europe Influenzavirus B Infection Drug Consumption (2017-2022)

    • 7.4 China Influenzavirus B Infection Drug Consumption (2017-2022)

    • 7.5 Japan Influenzavirus B Infection Drug Consumption (2017-2022)

    • 7.6 India Influenzavirus B Infection Drug Consumption (2017-2022)

    • 7.7 South Korea Influenzavirus B Infection Drug Consumption (2017-2022)

    8 Region and Country-wise Influenzavirus B Infection Drug Market Analysis and Outlook to 2028

    • 8.1 Global Influenzavirus B Infection Drug Consumption Forecast (2022-2028)

    • 8.2 United States Influenzavirus B Infection Drug Consumption Forecast (2022-2028)

    • 8.3 Europe Influenzavirus B Infection Drug Consumption Forecast (2022-2028)

    • 8.4 China Influenzavirus B Infection Drug Consumption Forecast (2022-2028)

    • 8.5 Japan Influenzavirus B Infection Drug Consumption Forecast (2022-2028)

    • 8.6 India Influenzavirus B Infection Drug Consumption Forecast (2022-2028)

    • 8.7 South Korea Influenzavirus B Infection Drug Consumption Forecast (2022-2028)

    9 Global Influenzavirus B Infection Drug Market Outlook by Types and Applications to 2022

    • 9.1 Global Influenzavirus B Infection Drug Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global APP-309 Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global CF-403 Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global GC-3106A Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global KIN-1400 Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Influenzavirus B Infection Drug Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Clinic Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Influenzavirus B Infection Drug Market Outlook by Types and Applications to 2028

    • 10.1 Global Influenzavirus B Infection Drug Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global APP-309 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global CF-403 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global GC-3106A Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global KIN-1400 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Influenzavirus B Infection Drug Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Clinic Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Influenzavirus B Infection Drug Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Influenzavirus B Infection Drug Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Influenzavirus B Infection Drug Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Influenzavirus B Infection Drug Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Influenzavirus B Infection Drug Market Competitive Analysis

    • 14.1 Aphios Corp

      • 14.1.1 Aphios Corp Company Details

      • 14.1.2 Aphios Corp Influenzavirus B Infection Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Aphios Corp Influenzavirus B Infection Drug Product and Service

    • 14.2 Adimmune Corp

      • 14.2.1 Adimmune Corp Company Details

      • 14.2.2 Adimmune Corp Influenzavirus B Infection Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Adimmune Corp Influenzavirus B Infection Drug Product and Service

    • 14.3 Cadila Healthcare Ltd

      • 14.3.1 Cadila Healthcare Ltd Company Details

      • 14.3.2 Cadila Healthcare Ltd Influenzavirus B Infection Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Cadila Healthcare Ltd Influenzavirus B Infection Drug Product and Service

    • 14.4 Green Cross Corp

      • 14.4.1 Green Cross Corp Company Details

      • 14.4.2 Green Cross Corp Influenzavirus B Infection Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Green Cross Corp Influenzavirus B Infection Drug Product and Service

    • 14.5 Shionogi & Co Ltd

      • 14.5.1 Shionogi & Co Ltd Company Details

      • 14.5.2 Shionogi & Co Ltd Influenzavirus B Infection Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Shionogi & Co Ltd Influenzavirus B Infection Drug Product and Service

    • 14.6 Inovio Pharmaceuticals Inc

      • 14.6.1 Inovio Pharmaceuticals Inc Company Details

      • 14.6.2 Inovio Pharmaceuticals Inc Influenzavirus B Infection Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Inovio Pharmaceuticals Inc Influenzavirus B Infection Drug Product and Service

    • 14.7 GlaxoSmithKline Plc

      • 14.7.1 GlaxoSmithKline Plc Company Details

      • 14.7.2 GlaxoSmithKline Plc Influenzavirus B Infection Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 GlaxoSmithKline Plc Influenzavirus B Infection Drug Product and Service

    • 14.8 Mucosis BV

      • 14.8.1 Mucosis BV Company Details

      • 14.8.2 Mucosis BV Influenzavirus B Infection Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Mucosis BV Influenzavirus B Infection Drug Product and Service

    • 14.9 SK Chemicals Co Ltd

      • 14.9.1 SK Chemicals Co Ltd Company Details

      • 14.9.2 SK Chemicals Co Ltd Influenzavirus B Infection Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 SK Chemicals Co Ltd Influenzavirus B Infection Drug Product and Service

    • 14.10 Sanofi Pasteur SA

      • 14.10.1 Sanofi Pasteur SA Company Details

      • 14.10.2 Sanofi Pasteur SA Influenzavirus B Infection Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Sanofi Pasteur SA Influenzavirus B Infection Drug Product and Service

    • 14.11 ContraFect Corp

      • 14.11.1 ContraFect Corp Company Details

      • 14.11.2 ContraFect Corp Influenzavirus B Infection Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 ContraFect Corp Influenzavirus B Infection Drug Product and Service

    • 14.12 TSRL Inc

      • 14.12.1 TSRL Inc Company Details

      • 14.12.2 TSRL Inc Influenzavirus B Infection Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 TSRL Inc Influenzavirus B Infection Drug Product and Service

    • 14.13 Medicago Inc

      • 14.13.1 Medicago Inc Company Details

      • 14.13.2 Medicago Inc Influenzavirus B Infection Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Medicago Inc Influenzavirus B Infection Drug Product and Service

    • 14.14 Amarillo Biosciences Inc

      • 14.14.1 Amarillo Biosciences Inc Company Details

      • 14.14.2 Amarillo Biosciences Inc Influenzavirus B Infection Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Amarillo Biosciences Inc Influenzavirus B Infection Drug Product and Service

    • 14.15 Vaxart Inc

      • 14.15.1 Vaxart Inc Company Details

      • 14.15.2 Vaxart Inc Influenzavirus B Infection Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Vaxart Inc Influenzavirus B Infection Drug Product and Service

    • 14.16 Daiichi Sankyo Company Ltd

      • 14.16.1 Daiichi Sankyo Company Ltd Company Details

      • 14.16.2 Daiichi Sankyo Company Ltd Influenzavirus B Infection Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Daiichi Sankyo Company Ltd Influenzavirus B Infection Drug Product and Service

    • 14.17 Kineta Inc

      • 14.17.1 Kineta Inc Company Details

      • 14.17.2 Kineta Inc Influenzavirus B Infection Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 Kineta Inc Influenzavirus B Infection Drug Product and Service

    • 14.18 Fujifilm Holdings Corporation

      • 14.18.1 Fujifilm Holdings Corporation Company Details

      • 14.18.2 Fujifilm Holdings Corporation Influenzavirus B Infection Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.18.3 Fujifilm Holdings Corporation Influenzavirus B Infection Drug Product and Service

    • 14.19 Novavax Inc

      • 14.19.1 Novavax Inc Company Details

      • 14.19.2 Novavax Inc Influenzavirus B Infection Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.19.3 Novavax Inc Influenzavirus B Infection Drug Product and Service

    • 14.20 BioCryst Pharmaceuticals Inc

      • 14.20.1 BioCryst Pharmaceuticals Inc Company Details

      • 14.20.2 BioCryst Pharmaceuticals Inc Influenzavirus B Infection Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.20.3 BioCryst Pharmaceuticals Inc Influenzavirus B Infection Drug Product and Service

    • 14.21 Romark Laboratories LC

      • 14.21.1 Romark Laboratories LC Company Details

      • 14.21.2 Romark Laboratories LC Influenzavirus B Infection Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.21.3 Romark Laboratories LC Influenzavirus B Infection Drug Product and Service

    • 14.22 Romark Laboratories LC Pasteur SA

      • 14.22.1 Romark Laboratories LC Pasteur SA Company Details

      • 14.22.2 Romark Laboratories LC Pasteur SA Influenzavirus B Infection Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.22.3 Romark Laboratories LC Pasteur SA Influenzavirus B Infection Drug Product and Service

    • 14.23 Altravax Inc

      • 14.23.1 Altravax Inc Company Details

      • 14.23.2 Altravax Inc Influenzavirus B Infection Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.23.3 Altravax Inc Influenzavirus B Infection Drug Product and Service

    • 14.24 MedImmune LLC

      • 14.24.1 MedImmune LLC Company Details

      • 14.24.2 MedImmune LLC Influenzavirus B Infection Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.24.3 MedImmune LLC Influenzavirus B Infection Drug Product and Service

    • 14.25 Vectura Group Plc

      • 14.25.1 Vectura Group Plc Company Details

      • 14.25.2 Vectura Group Plc Influenzavirus B Infection Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.25.3 Vectura Group Plc Influenzavirus B Infection Drug Product and Service

    • 14.26 AbbVie Inc

      • 14.26.1 AbbVie Inc Company Details

      • 14.26.2 AbbVie Inc Influenzavirus B Infection Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.26.3 AbbVie Inc Influenzavirus B Infection Drug Product and Service

    • 14.27 Park Active Molecules

      • 14.27.1 Park Active Molecules Company Details

      • 14.27.2 Park Active Molecules Influenzavirus B Infection Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.27.3 Park Active Molecules Influenzavirus B Infection Drug Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Influenzavirus B Infection Drug

    • Figure Influenzavirus B Infection Drug Picture

    • Table Global Influenzavirus B Infection Drug Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Influenzavirus B Infection Drug Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Influenzavirus B Infection Drug Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Influenzavirus B Infection Drug Consumption by Country (2017-2022)

    • Figure United States Influenzavirus B Infection Drug Consumption and Growth Rate (2017-2022)

    • Table Europe Influenzavirus B Infection Drug Consumption and Growth Rate (2017-2022)

    • Figure China Influenzavirus B Infection Drug Consumption and Growth Rate (2017-2022)

    • Figure Japan Influenzavirus B Infection Drug Consumption and Growth Rate (2017-2022)

    • Figure India Influenzavirus B Infection Drug Consumption and Growth Rate (2017-2022)

    • Figure South Korea Influenzavirus B Infection Drug Consumption and Growth Rate (2017-2022)

    • Figure Global Influenzavirus B Infection Drug Consumption Forecast by Country (2022-2028)

    • Figure United States Influenzavirus B Infection Drug Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Influenzavirus B Infection Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Influenzavirus B Infection Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Influenzavirus B Infection Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Influenzavirus B Infection Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Influenzavirus B Infection Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global APP-309 Consumption and Growth Rate (2017-2022)

    • Figure Global CF-403 Consumption and Growth Rate (2017-2022)

    • Figure Global GC-3106A Consumption and Growth Rate (2017-2022)

    • Figure Global KIN-1400 Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Clinic Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global APP-309 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global CF-403 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global GC-3106A Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global KIN-1400 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Influenzavirus B Infection Drug Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Influenzavirus B Infection Drug Export by Region (Top 5 Countries) (2017-2028)

    • Table Aphios Corp (Foundation Year, Company Profile and etc.)

    • Table Aphios Corp Influenzavirus B Infection Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Aphios Corp Influenzavirus B Infection Drug Product and Service

    • Table Adimmune Corp (Foundation Year, Company Profile and etc.)

    • Table Adimmune Corp Influenzavirus B Infection Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Adimmune Corp Influenzavirus B Infection Drug Product and Service

    • Table Cadila Healthcare Ltd (Foundation Year, Company Profile and etc.)

    • Table Cadila Healthcare Ltd Influenzavirus B Infection Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cadila Healthcare Ltd Influenzavirus B Infection Drug Product and Service

    • Table Green Cross Corp (Foundation Year, Company Profile and etc.)

    • Table Green Cross Corp Influenzavirus B Infection Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Green Cross Corp Influenzavirus B Infection Drug Product and Service

    • Table Shionogi & Co Ltd (Foundation Year, Company Profile and etc.)

    • Table Shionogi & Co Ltd Influenzavirus B Infection Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shionogi & Co Ltd Influenzavirus B Infection Drug Product and Service

    • Table Inovio Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)

    • Table Inovio Pharmaceuticals Inc Influenzavirus B Infection Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Inovio Pharmaceuticals Inc Influenzavirus B Infection Drug Product and Service

    • Table GlaxoSmithKline Plc (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Plc Influenzavirus B Infection Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Plc Influenzavirus B Infection Drug Product and Service

    • Table Mucosis BV (Foundation Year, Company Profile and etc.)

    • Table Mucosis BV Influenzavirus B Infection Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mucosis BV Influenzavirus B Infection Drug Product and Service

    • Table SK Chemicals Co Ltd (Foundation Year, Company Profile and etc.)

    • Table SK Chemicals Co Ltd Influenzavirus B Infection Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table SK Chemicals Co Ltd Influenzavirus B Infection Drug Product and Service

    • Table Sanofi Pasteur SA (Foundation Year, Company Profile and etc.)

    • Table Sanofi Pasteur SA Influenzavirus B Infection Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Pasteur SA Influenzavirus B Infection Drug Product and Service

    • Table ContraFect Corp (Foundation Year, Company Profile and etc.)

    • Table ContraFect Corp Influenzavirus B Infection Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table ContraFect Corp Influenzavirus B Infection Drug Product and Service

    • Table TSRL Inc (Foundation Year, Company Profile and etc.)

    • Table TSRL Inc Influenzavirus B Infection Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table TSRL Inc Influenzavirus B Infection Drug Product and Service

    • Table Medicago Inc (Foundation Year, Company Profile and etc.)

    • Table Medicago Inc Influenzavirus B Infection Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Medicago Inc Influenzavirus B Infection Drug Product and Service

    • Table Amarillo Biosciences Inc (Foundation Year, Company Profile and etc.)

    • Table Amarillo Biosciences Inc Influenzavirus B Infection Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amarillo Biosciences Inc Influenzavirus B Infection Drug Product and Service

    • Table Vaxart Inc (Foundation Year, Company Profile and etc.)

    • Table Vaxart Inc Influenzavirus B Infection Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Vaxart Inc Influenzavirus B Infection Drug Product and Service

    • Table Daiichi Sankyo Company Ltd (Foundation Year, Company Profile and etc.)

    • Table Daiichi Sankyo Company Ltd Influenzavirus B Infection Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Daiichi Sankyo Company Ltd Influenzavirus B Infection Drug Product and Service

    • Table Kineta Inc (Foundation Year, Company Profile and etc.)

    • Table Kineta Inc Influenzavirus B Infection Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Kineta Inc Influenzavirus B Infection Drug Product and Service

    • Table Fujifilm Holdings Corporation (Foundation Year, Company Profile and etc.)

    • Table Fujifilm Holdings Corporation Influenzavirus B Infection Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Fujifilm Holdings Corporation Influenzavirus B Infection Drug Product and Service

    • Table Novavax Inc (Foundation Year, Company Profile and etc.)

    • Table Novavax Inc Influenzavirus B Infection Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novavax Inc Influenzavirus B Infection Drug Product and Service

    • Table BioCryst Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)

    • Table BioCryst Pharmaceuticals Inc Influenzavirus B Infection Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table BioCryst Pharmaceuticals Inc Influenzavirus B Infection Drug Product and Service

    • Table Romark Laboratories LC (Foundation Year, Company Profile and etc.)

    • Table Romark Laboratories LC Influenzavirus B Infection Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Romark Laboratories LC Influenzavirus B Infection Drug Product and Service

    • Table Romark Laboratories LC Pasteur SA (Foundation Year, Company Profile and etc.)

    • Table Romark Laboratories LC Pasteur SA Influenzavirus B Infection Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Romark Laboratories LC Pasteur SA Influenzavirus B Infection Drug Product and Service

    • Table Altravax Inc (Foundation Year, Company Profile and etc.)

    • Table Altravax Inc Influenzavirus B Infection Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Altravax Inc Influenzavirus B Infection Drug Product and Service

    • Table MedImmune LLC (Foundation Year, Company Profile and etc.)

    • Table MedImmune LLC Influenzavirus B Infection Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table MedImmune LLC Influenzavirus B Infection Drug Product and Service

    • Table Vectura Group Plc (Foundation Year, Company Profile and etc.)

    • Table Vectura Group Plc Influenzavirus B Infection Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Vectura Group Plc Influenzavirus B Infection Drug Product and Service

    • Table AbbVie Inc (Foundation Year, Company Profile and etc.)

    • Table AbbVie Inc Influenzavirus B Infection Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table AbbVie Inc Influenzavirus B Infection Drug Product and Service

    • Table Park Active Molecules (Foundation Year, Company Profile and etc.)

    • Table Park Active Molecules Influenzavirus B Infection Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Park Active Molecules Influenzavirus B Infection Drug Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US